Market capitalization | $98.19m |
Enterprise Value | $74.21m |
P/E (TTM) P/E ratio | 10.08 |
EV/FCF (TTM) EV/FCF | 5.49 |
EV/Sales (TTM) EV/Sales | 0.72 |
P/S ratio (TTM) P/S ratio | 0.95 |
P/B ratio (TTM) P/B ratio | 0.59 |
Revenue growth (TTM) Revenue growth | 4.30% |
Revenue (TTM) Revenue | $102.89m |
As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.
Jun '24 |
+/-
%
|
||
Revenue | 103 103 |
4%
4%
|
|
Gross Profit | 45 45 |
1%
1%
|
|
EBITDA | 25 25 |
7%
7%
|
EBIT (Operating Income) EBIT | 17 17 |
12%
12%
|
Net Profit | 11 11 |
13%
13%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
FONAR Corp. engages in the design, manufacture, sale, and servicing of magnetic resonance imaging scanners. It operates through the Manufacturing and Servicing of Medical Equipment; and Management of Diagnostic Imaging Center segments. The Manufacturing and Servicing of Medical Equipment segment promotes its product, Fonar Upright MRI. The Management of Diagnostic Imaging Center segment offers management, administrative, billing and collection services, office space, equipment, repair, maintenance service and clerical, and non-medical personnel to medical providers through its subsidiary, Health Management Corp. of America. The company was founded by Raymond V. Damadian on July 17, 1978 and is headquartered in Melville, NY.
Head office | United States |
CEO | Timothy Damadian |
Employees | 520 |
Founded | 1978 |
Website | www.fonar.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.